(Circulation. 1997;96:821-826.)
© 1997 American Heart Association, Inc.
Articles |
Abnormal Cardiac Adrenergic Nerve Function in Patients With Syndrome X Detected By [123I]Metaiodobenzylguanidine Myocardial Scintigraphy
From the Istituto di Cardiologia (G.A.L., C.P., C.T., F.C., A.M.) and Istituto di Medicina Nucleare (A.G., M.L.C., G.M., L.T.), Università Cattolica del Sacro Cuore, Rome, and Sorin Biomedia Diagnostics (R.F.), Saluggia, Italy.
Correspondence to Gaetano A. Lanza, MD, Istituto di Cardiologia, Università Cattolica del Sacro Cuore, L.go A. Gemelli, 8, 00168 Roma, Italy.
Background Previous studies have suggested that an abnormal cardiac adrenergic tone may have a pathophysiological role in syndrome X (effort angina, positive exercise testing, angiographically normal coronary arteries).
Methods and Results To evaluate cardiac adrenergic nerve function, we performed [123I]metaiodobenzylguanidine (MIBG) myocardial scintigraphy in 12 patients with syndrome X and 10 control subjects. Cardiac MIBG uptake was assessed by the heart/mediastinum (H/M) ratio and by an MIBG uptake defect score (higher values=lower uptake). In syndrome X patients, we also correlated MIBG scintigraphic findings with stress myocardial perfusion as assessed by 201Tl scintigraphy. An inferior MIBG defect was observed in only 1 control subject, whereas 9 patients (P<.01) showed MIBG defects. The heart was totally or almost totally invisible on MIBG images in 5 patients, and predominantly regional defects were observed in 4. The H/M ratio was lower (1.70±0.6 versus 2.2±0.3, P=.03) and MIBG uptake defect score higher (35±31 versus 4±2, P=.003) in syndrome X patients. Reversible stress thallium perfusion defects were found in 62% of patients with MIBG defects but in no patient with normal MIBG uptake. MIBG defects persisted unchanged in 7 patients at a 5±3-month follow-up study.
Conclusions In this study, obvious defects in global and/or regional cardiac MIBG uptake, indicating an abnormal cardiac adrenergic nerve function, were detected in 75% of patients with syndrome X. These findings strongly support the cardiac origin of chest pain in syndrome X, although the mechanisms and the pathophysiological meaning of the abnormal cardiac MIBG uptake in these patients deserve further investigation.
Key Words: syndrome X • nervous system, adrenergic • scintigraphy
This article has been cited by other articles:
 |
|
 |
|
  F. Crea, P. G. Camici, R. De Caterina, and G. A. Lanza CHAPTER 17 Chronic Ischaemic Heart Disease ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Lanza, A. Buffon, A. Sestito, L. Natale, G. A. Sgueglia, L. Galiuto, F. Infusino, L. Mariani, A. Centola, and F. Crea Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J. Am. Coll. Cardiol., January 29, 2008; 51(4): 466 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yazici, S. Demircan, K. Durna, and M. Sahin The Role of Adrenergic Activity in Slow Coronary Flow and Its Relationship to TIMI Frame Count Angiology, September 1, 2007; 58(4): 393 - 400. [Abstract] [PDF]
|
|
|
|
 |
|
 G. Angelo Sgueglia, A. Sestito, A. Spinelli, B. Cioni, F. Infusino, F. Papacci, F. Bellocci, M. Meglio, F. Crea, and G. Antonio Lanza Long-term follow-up of patients with cardiac syndrome X treated by spinal cord stimulation Heart, May 1, 2007; 93(5): 591 - 597. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Madaric, J. Bartunek, K. Verhamme, M. Penicka, E. Van Schuerbeeck, P. Nellens, G. R. Heyndrickx, W. Wijns, M. Vanderheyden, and B. De Bruyne Hyperdynamic Myocardial Response to Beta-Adrenergic Stimulation in Patients With Chest Pain and Normal Coronary Arteries J. Am. Coll. Cardiol., October 4, 2005; 46(7): 1270 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. A. Lanza, A. Sestito, G. A. Sgueglia, F. Infusino, F. Papacci, M. Visocchi, C. Ierardi, M. Meglio, F. Bellocci, and F. Crea Effect of spinal cord stimulation on spontaneous and stress-induced angina and 'ischemia-like' ST-segment depression in patients with cardiac syndrome X Eur. Heart J., May 2, 2005; 26(10): 983 - 989. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Valeriani, A. Sestito, D. L. Pera, L. D. Armas, F. Infusino, T. Maiese, G. A. Sgueglia, P. A. Tonali, F. Crea, D. Restuccia, et al. Abnormal cortical pain processing in patients with cardiac syndrome X Eur. Heart J., May 2, 2005; 26(10): 975 - 982. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Senen, M. Ileri, A. Alper, F. Yetkin, R. Atak, I. Hisar, E. Yetkin, H. Turhan, H. Bardakci, and D. Demirkan Increased Levels of Soluble Adhesion Molecules E-Selectin and P-Selectin in Patients with Cardiac Syndrome X Angiology, May 1, 2005; 56(3): 273 - 277. [Abstract] [PDF]
|
|
|
|
|
|
F. Crea and G. A Lanza Angina pectoris and normal coronary arteries: cardiac syndrome X Heart, April 1, 2004; 90(4): 457 - 463. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Maseri and Endorsed by the American College of Cardiology Fou Women's Ischemic Syndrome Evaluation: Current Status and Future Research Directions: Report of the National Heart, Lung and Blood Institute Workshop: October 2-4, 2002: Perspective: New Frontiers in Detection of Ischemic Heart Disease in Women Circulation, February 17, 2004; 109 (6): e62 - e63. [Full Text] [PDF]
|
|
|
|
|
|
J. C. Kaski Pathophysiology and Management of Patients With Chest Pain and Normal Coronary Arteriograms (Cardiac Syndrome X) Circulation, February 10, 2004; 109(5): 568 - 572. [Full Text] [PDF]
|
|
|
|
|
|
G. A. Lanza, A. Sestito, S. Iacovella, L. Morlacchi, E. Romagnoli, G. Schiavoni, F. Crea, A. Maseri, and F. Andreotti Relation Between Platelet Response to Exercise and Coronary Angiographic Findings in Patients With Effort Angina Circulation, March 18, 2003; 107(10): 1378 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G A Lanza and F Crea The complex link between brain and heart in cardiac syndrome X Heart, October 1, 2002; 88(4): 328 - 330. [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Panting, P. D. Gatehouse, G.-Z. Yang, F. Grothues, D. N. Firmin, P. Collins, and D. J. Pennell Abnormal Subendocardial Perfusion in Cardiac Syndrome X Detected by Cardiovascular Magnetic Resonance Imaging N. Engl. J. Med., June 20, 2002; 346(25): 1948 - 1953. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Shimizu, K Chin, T Nakamura, H Masuzaki, Y Ogawa, R Hosokawa, A Niimi, N Hattori, R Nohara, S Sasayama, et al. Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome Thorax, May 1, 2002; 57(5): 429 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. D Rosen The pathophysiology of cardiac syndrome X -- a tale of paradigm shifts Cardiovasc Res, November 1, 2001; 52(2): 174 - 177. [Full Text] [PDF]
|
|
|
|
|
|
G. Gulli, R. Cemin, P. Pancera, G. Menegatti, C. Vassanelli, and A. Cevese Evidence of parasympathetic impairment in some patients with cardiac syndrome X Cardiovasc Res, November 1, 2001; 52(2): 208 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.A. Lanza, F. Andreotti, A. Sestito, A. Sciahbasi, F. Crea, and A. Maseri Platelet aggregability in cardiac syndrome X Eur. Heart J., October 2, 2001; 22(20): 1924 - 1930. [Abstract] [PDF]
|
|
|
|
|
|
P. K. Goel, S. K. Gupta, A. Agarwal, and A. Kapoor Slow Coronary Flow: A Distinct Angiographic Subgroup in Syndrome X Angiology, August 1, 2001; 52(8): 507 - 514. [Abstract] [PDF]
|
|
|
|
|
|
E.N Simantirakis, V.K Prassopoulos, S.I Chrysostomakis, G.E Kochiadakis, S.I Koukouraki, J.P Lekakis, N.S Karkavitsas, and P.E Vardas Effects of asynchronous ventricular activation on myocardial adrenergic innervation in patients with permanent dual-chamber pacemakers. An I123-metaiodobenzylguanidine cardiac scintigraphic study Eur. Heart J., February 2, 2001; 22(4): 323 - 332. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Buffon, S. Rigattieri, S. A. Santini, V. Ramazzotti, F. Crea, B. Giardina, and A. Maseri Myocardial ischemia-reperfusion damage after pacing-induced tachycardia in patients with cardiac syndrome X Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2627 - H2633. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gaspardone, C. Ferri, F. Crea, F. Versaci, F. Tomai, A. Santucci, L. Chiariello, and P. A. Gioffre Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X: A potential link between cardiac and metabolic syndrome X J. Am. Coll. Cardiol., December 1, 1998; 32(7): 2031 - 2034. [Abstract] [Full Text] [PDF]
|
|